Teva, Heptares Announce Agreement to Discover and Develop Novel, Small-Molecule CGRP Antagonists for Treatment of Migraine
November 25, 2015 at 04:13 AM EST
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) and Heptares Therapeutics ("Heptares"), a wholly owned subsidiary of ...
